| 000 | 01829 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250511201613.0 | ||
| 264 | 0 | _c19910703 | |
| 008 | 199107s 0 0 eng d | ||
| 022 | _a0006-2952 | ||
| 024 | 7 |
_a10.1016/0006-2952(91)90120-t _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Clercq, E | |
| 245 | 0 | 0 |
_aBroad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _cJun 1991 |
||
| 300 |
_a1821-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAmides |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aAzauridine _xpharmacology |
| 650 | 0 | 4 | _aCarbon-Nitrogen Ligases |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCytarabine _xpharmacology |
| 650 | 0 | 4 |
_aCytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDeoxycytidine _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 |
_aHeLa Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLigases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNucleosides _xpharmacology |
| 650 | 0 | 4 | _aPyrazoles |
| 650 | 0 | 4 |
_aRibavirin _xpharmacology |
| 650 | 0 | 4 |
_aRibonucleosides _xpharmacology |
| 650 | 0 | 4 | _aRibose |
| 650 | 0 | 4 |
_aThymidine _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUracil _xanalogs & derivatives |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 650 | 0 | 4 |
_aViruses _xdrug effects |
| 700 | 1 | _aMurase, J | |
| 700 | 1 | _aMarquez, V E | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 41 _gno. 12 _gp. 1821-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(91)90120-t _zAvailable from publisher's website |
| 999 |
_c1716523 _d1716523 |
||